{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:30Z","timestamp":1782602550386,"version":"3.54.5"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.9482","type":"journal-article","created":{"date-parts":[[2013,6,30]],"date-time":"2013-06-30T22:55:31Z","timestamp":1372632931000},"page":"1503-1507","source":"Crossref","is-referenced-by-count":68,"title":["Successful Treatment of a Patient with Multicentric Castleman's Disease who Presented with Thrombocytopenia, Ascites, Renal Failure and Myelofibrosis Using Tocilizumab, an Anti-Interleukin-6 Receptor Antibody"],"prefix":"10.2169","volume":"52","author":[{"given":"Hiroshi","family":"Kawabata","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Katsurada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ijinkai Takeda General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9: 822-830, 1956.","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29: 670-683, 1972.","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease. Blood 74: 1360-1367, 1989.","DOI":"10.1182\/blood.V74.4.1360.bloodjournal7441360"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Karcher DS, Alkan S. Herpes-like DNA sequences, aids-related tumors, and Castleman's disease. N Engl J Med 333: 797-798; author reply 798-799, 1995.","DOI":"10.1056\/NEJM199509213331211"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86: 1276-1280, 1995.","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95: 1406-1412, 2000.","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stebbing J, Adams C, Sanitt A, et al. Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease. Blood 118: 271-275, 2011.","DOI":"10.1182\/blood-2011-02-335620"},{"key":"8","unstructured":"8. Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multicentric Castleman disease among Japanese: A report of 28 cases. Int J Surg Pathol 16: 391-398, 2008."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.","DOI":"10.1002\/art.1780251101"},{"key":"10","unstructured":"10. Kojima M, Nakamura N, Tsukamoto N, et al. Multicentric Castleman's disease representing effusion at initial clinical presentation: Clinicopathological study of seven cases. Lupus 20: 44-50, 2011."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol 24: 76-83, 2012.","DOI":"10.1097\/BOR.0b013e32834db525"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Awano N, Inomata M, Kondoh K, et al. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis. Intern Med 51: 3061-3066, 2012.","DOI":"10.2169\/internalmedicine.51.8120"},{"key":"13","unstructured":"13. Takai K, Nikkuni K, Shibuya H, et al. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51: 320-325, 2010."},{"key":"14","unstructured":"14. Pullarkat V, Bass RD, Gong JZ, et al. Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome. Am J Hematol 72: 8-12, 2003."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/13\/52_52.9482\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:43Z","timestamp":1621446583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/13\/52_52.9482\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.9482","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}